Literature DB >> 19001871

Identification of beta-catenin as a novel substrate of Polo-like kinase 1.

Tsuyoshi Arai1, Kyosuke Haze, Yuko Iimura-Morita, Takumitsu Machida, Masato Iida, Kenji Tanaka, Hideya Komatani.   

Abstract

Polo-like kinase 1 (Plk1) is a serine/threonine kinase that plays an important role in M phase progression by regulating various downstream substrates via phosphorylation. Here, we identified beta-catenin as a novel substrate of Plk1 and determined that Ser-718 is a phosphorylation site for Plk1 by using a phospho-specific antibody that cross-reacts with Plk1-dependent phosphorylation sites. Ser-718 of beta-catenin was directly phosphorylated by recombinant Plk1 in vitro, with the phosphorylation signal in cells increasing with overexpression of Plk1 and decreasing when endogenous Plk1 was depleted by small interfering RNA. The phosphorylation at Ser-718 was correlated with the cell cycle-dependent expression of Plk1 which reached a maximum in M phase. We also confirmed that there is a physical interaction between beta-catenin and Plk1 using coimmunoprecipitation and a GST pull-down assay. These results demonstrate that beta-catenin is a physiological substrate of Plk1 in cells, which may provide a novel insight into the role of beta-catenin in M phase.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19001871     DOI: 10.4161/cc.7.22.7072

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  10 in total

Review 1.  Polo-box domain: a versatile mediator of polo-like kinase function.

Authors:  Jung-Eun Park; Nak-Kyun Soung; Yoshikazu Johmura; Young H Kang; Chenzhong Liao; Kyung H Lee; Chi Hoon Park; Marc C Nicklaus; Kyung S Lee
Journal:  Cell Mol Life Sci       Date:  2010-02-11       Impact factor: 9.261

2.  Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay.

Authors:  Heying Cui; Kyle M Loftus; Crystal R Noell; Sozanne R Solmaz
Journal:  J Vis Exp       Date:  2018-05-03       Impact factor: 1.355

3.  Serum inducible kinase is a positive regulator of cortical dendrite development and is required for BDNF-promoted dendritic arborization.

Authors:  Shun-Ling Guo; Guo-He Tan; Shuai Li; Xue-Wen Cheng; Ya Zhou; Yun-Fang Jia; Hui Xiong; Jiong Tao; Zhi-Qi Xiong
Journal:  Cell Res       Date:  2011-06-21       Impact factor: 25.617

4.  Multiplexed random peptide library and phospho-specific antibodies facilitate human polo-like kinase 1 inhibitor screen.

Authors:  Kenji Tanaka; Mitsunori Koresawa; Masato Iida; Kazuhiro Fukasawa; Erica Stec; Jason Cassaday; Peter Chase; Keith Rickert; Peter Hodder; Toshimitsu Takagi; Hideya Komatani
Journal:  Assay Drug Dev Technol       Date:  2010-02       Impact factor: 1.738

Review 5.  Coordinating cellular events during spermatogenesis: a biochemical model.

Authors:  Pearl P Y Lie; C Yan Cheng; Dolores D Mruk
Journal:  Trends Biochem Sci       Date:  2009-06-15       Impact factor: 13.807

Review 6.  The role of polo-like kinase 1 in carcinogenesis: cause or consequence?

Authors:  Brian D Cholewa; Xiaoqi Liu; Nihal Ahmad
Journal:  Cancer Res       Date:  2013-11-21       Impact factor: 12.701

7.  The transcription factor YY1 is a substrate for Polo-like kinase 1 at the G2/M transition of the cell cycle.

Authors:  Raed Rizkallah; Karen E Alexander; Ari Kassardjian; Bernhard Lüscher; Myra M Hurt
Journal:  PLoS One       Date:  2011-01-06       Impact factor: 3.240

Review 8.  Regulatory functional territory of PLK-1 and their substrates beyond mitosis.

Authors:  Shiv Kumar; Garima Sharma; Chiranjib Chakraborty; Ashish Ranjan Sharma; Jaebong Kim
Journal:  Oncotarget       Date:  2017-06-06

Review 9.  Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling.

Authors:  Kinjal Shah; Julhash U Kazi
Journal:  Front Oncol       Date:  2022-03-14       Impact factor: 6.244

10.  Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signaling identifies therapeutic targets for colorectal cancer.

Authors:  Chunhua Wan; Sylvia Mahara; Claire Sun; Anh Doan; Hui Kheng Chua; Dakang Xu; Jia Bian; Yue Li; Danxi Zhu; Dhanya Sooraj; Tomasz Cierpicki; Jolanta Grembecka; Ron Firestein
Journal:  Sci Adv       Date:  2021-05-19       Impact factor: 14.136

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.